Technology

Silo Pharma's QwikAgents Subsidiary Expands AI Agent Platform With New Client, To Support Client-Provided Nvidia API Keys, Adds Hermes Agent Runtime

Sep 30, 2026 · 08:53 AM ET· updated 1h ago

Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent

Why It Matters

Silo Pharma's AI division added a new customer and a tool called Hermes. This shows the AI business is growing and working with more companies.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SILO1.54

-0.07 (-4.35%)

NVDA231.00

+3.79 (+1.67%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.